Edited by Peter Hillerberg6 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The street leaned bearish this week. Downgrades outnumbered upgrades across the week of October 5, with concentrated selling pressure from analysts on industrial software, homebuilders, and financials. Two names, PTC and OPCH, each triggered multi-firm capitulation events in a single session, underscoring how quickly consensus can shift after sharp price moves.
HOG received a Citigroup upgrade to Buy, with the target raised to $33.
Deutsche Bank upgraded BYD to Buy, lifting the target to $99 from $98. The same firm upgraded to Buy with a $25 target, up from $23, implying 65% upside from its $15.10 close. Short interest on PENN stood at 12.8% of free float, up 23% over the prior month.
BTIG analyst Mark Massaro upgraded NEO to Buy with a $28 target, implying 46% upside from $19.13.
Barclays upgraded QGEN to Overweight, raising the target 37.5% to $55. The same firm upgraded FTRE to Overweight with a $23 target.
Evercore ISI upgraded PG to Outperform, raising the target to $166 from $161.
B. Riley upgraded SWKS to Buy, raising the target 57% to $107, citing 6G and AI data centre upside.
Morgan Stanley upgraded BWA to Overweight, lifting the target 34% to $95 from $71.
Evercore upgraded NTAP to Outperform, raising the target 43% to $300, citing hybrid cloud momentum.
Cantor Fitzgerald upgraded HUM to Overweight with a $460 target, up 53%. Baird followed on Thursday, also upgrading to Outperform with a $596 target, citing Medicare Advantage margin recovery.
JP Morgan upgraded BBD to Overweight from Neutral, reversing its own November 2024 downgrade. The stock rose 18.6% on the day.
TD Cowen upgraded MRVL to Buy with a $350 target, up 43% from $245.
Goldman Sachs upgraded PLTR to Buy with a $230 target.
Raymond James upgraded ONB to Outperform with a $29 target, and OSBC to Strong Buy with a $30 target. PB was also lifted to Outperform with a $78 target.
Citigroup upgraded XPO to Buy with a $224 target, citing durable margin expansion in North American LTL operations.
KeyBanc upgraded GNRC to Overweight with a $280 target. The stock was up 18.1% over the prior month.
Oppenheimer upgraded GPN to Outperform with a $115 target. The stock was down 12.4% on the month.
Jefferies upgraded RCL to Buy with a $330 target ahead of the cruise operator's October 27 earnings.
UBS assumed coverage of BEN with a Buy rating, raising the target 74% to $40.
UBS upgraded PFLT to Buy from Neutral.
Wolfe Research upgraded ODFL to Peer Perform from Underperform.
Gordon Haskett upgraded DG to Buy from Hold with a $140 target. The stock was down 10.4% over the prior month.
KeyBanc upgraded JKHY to Overweight.
Wells Fargo upgraded CLF to Overweight with a $14 target.
Truist upgraded BAH to Buy with an $85 target.
Freedom Broker upgraded BKH to Buy with a $78 target.
Deutsche Bank upgraded CHYM to Buy with a $35 target.
PTC was downgraded by four firms in a single session on October 5: Rosenblatt cut to Neutral with a $205 target, Barclays, RBC, and KeyBanc also reduced ratings. BMO Capital followed with a Market Perform, raising the target to $205 while cutting the rating. Oppenheimer then downgraded to Perform from Outperform as the stock surged 33% in one day. By week's end, consensus stood at 2 Buy / 15 Hold with a mean target of $196.67 against a price of $192.26, following a 37% weekly rally.
OPCH saw five downgrades in a single day. Barrington, Jefferies, Citizens, JP Morgan, and UBS all cut ratings as the stock climbed 33% in one week. The mean analyst target settled at $30.39, just below the $31.00 close. The episode is a clear case of analysts pulling ratings after a price move, rather than ahead of it.
UBS downgraded OI to Neutral, cutting the target to $6.00 from $11.00.
Goldman Sachs downgraded GNTX to Sell, cutting the target to $20 from $23.
Piper Sandler downgraded GSHD to Neutral, slashing the target to $48 from $72.
Raymond James downgraded FULT to Market Perform, WSBC to Market Perform from Strong Buy, and HTH to Underperform from Market Perform, citing loan growth guidance cuts.
RBC Capital downgraded BLDR to Sector Perform, cutting the target 29.5% to $62. The same firm downgraded MHK to Underperform with a $112 target and OC to Sector Perform with a $127 target from $172. This cluster of homebuilding-related cuts signals growing concern about housing sector demand.
Keefe Bruyette downgraded PJT to Market Perform, cutting the target 18.5% to $159. The firm also cut VOYA to Market Perform and GNW to Market Perform.
HSBC downgraded BBD to Hold after the stock climbed 23% in a week, and cut ITUB to Hold and STZ to Hold with a 30% target cut to $135.
Goldman Sachs downgraded TYL to Neutral, cutting the target to $345 from $395.
Oppenheimer downgraded FISV to Perform, citing negative 5% organic revenue growth year over year.
JP Morgan downgraded LDOS to Neutral, cutting the target 11% to $142. The same firm cut DD to Neutral and ITW, citing margin pressure and weakening automotive OEM demand.
Jefferies downgraded RXO to Hold despite the stock surging 42% in one week. Multiple firms repriced RXO simultaneously: TD Cowen raised the target 73% to $30.25, and JP Morgan upgraded to Neutral from Underweight.
Barclays downgraded JOBY to Underweight with a $4 target, down 33%. Short interest on JOBY reached 13.8% of free float, its highest level in a month.
RBC downgraded KNF to Sector Perform, slashing the target 44% to $58 from $103.
Needham and Jefferies downgraded PCRX to Hold on the same day. JP Morgan upgraded the same stock to Neutral with a $36.50 target. HC Wainwright and Truist also cut ratings later in the week. The stock was up 44% in one week on an earnings beat, producing a split between covering analysts.
Citigroup issued a wave of semiconductor downgrades on October 8: OLED cut to Sell, NVMI cut to Neutral with the target down 24.5%, and NXPI cut to Neutral with the target down 30% to $260.
JP Morgan downgraded HUBS to Neutral, cutting the target to $240 from $268.
BNP Paribas downgraded CACI to Underperform, cutting the target to $540 from $675.
Industrial software and freight repriced sharply. PTC's 37% weekly rally triggered broad analyst capitulation across the software coverage universe. RXO saw a similar dynamic in freight brokerage, with four firms repricing within hours of a 22.5% single-day move. Both cases reflect analysts adjusting to price rather than driving it.
Homebuilders under pressure. RBC's triple downgrade of BLDR, MHK, and OC on October 7 concentrated bearish attention on housing-exposed names. The target cuts were steep, pointing to structural rather than cyclical concern.
Brazilian financials split the street. BBD surged 29% over the week, prompting a JP Morgan upgrade and an HSBC downgrade within two days of each other. ITUB also drew a Hold from HSBC on valuation. The divergence reflects uncertainty about how much of the Brazilian fintech and banking re-rating has already been priced in.
Semiconductors face Citigroup review. The October 8 cluster of cuts to OLED, NVMI, and NXPI from Citigroup signals a coordinated reassessment of chip sector valuations, with target reductions of 16% to 30%.
Healthcare managed care upgrades. HUM drew two separate upgrades in three days, from Cantor Fitzgerald and Baird, both citing Medicare Advantage margin recovery. The scale of the target increases (53%) is notable for a sector that has seen extended pressure.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
